$27.01
Today
as of Jul 22, 16:51 ET
Last 30 days
Recent Press Releases & News
A Mineralys Insider Banked a $557,000 Options Gain Before a December FDA Date
What to Know About This Mineralys Insider Sale Before a December FDA Date
A $500 Million Funding Deal Could Make Mineralys Therapeutics (MLYS) Stock A Multibagger
Overview
52-week range
$13
$48
41% of range
Avg surprise (last 3)
+15.3%
Avg reaction (last 2)
+2.7%
100% positive
Latest IV / EM
65%
EM ±14.9% · $25 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $-0.47 | $-0.51 | +7.8% | +40.5% | +2.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.52 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.66 | $-0.78 | +15.4% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.79 | $-1.02 | +22.6% | — | +2.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.13 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.83 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.70 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.57 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.31 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$0.57 | -$0.66 | +13.6% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-45M | — | $-41M | $-47M | $-44M | — | $-60M | $-45M |
| Net income | $-39M | — | $-37M | $-43M | $-42M | — | $-56M | $-41M |
| EPS (diluted) | $-0.47 | — | $-0.52 | $-0.66 | $-0.79 | — | $-1.13 | $-0.83 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $113M | $173M | $218M | $102M | $165M | $114M | $97M | $68M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $652M | $661M | $600M | $335M | $355M | $205M | $268M | $318M |
| Total assets | $653M | $662M | $600M | $336M | $355M | $206M | $268M | $318M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $638M | $647M | $576M | $314M | $342M | $191M | $237M | $290M |